GL1X · GenesisL1 explorer

MolNFT v1 · #149636 · protein

Crystal structure of a parallel six-helix coiled coil cc-TYPE2-il-sg

6G68: “Crystal structure of a parallel six-helix coiled coil cc-TYPE2-il-sg”. X-ray diffraction, 2 ligands (ACE, SO4), 2 pockets (best druggability 0.71). MolNFT v1 #149636 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6G68
Type
protein
Length
538 residues
Chains
18
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cc-TYPE2-il-sg
Ligands
ACE, SO4
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 93% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, H, I, J, K, L, M, O, P, Q, RCc-TYPE2-il-sgprotein3093% helix, 0% strand—
G, NCc-TYPE2-il-sgprotein2993% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 10 copies · chains A, F, B, C, D, E, J, K, M, Q, N, O
  • SO4 · Sulfate ion · ion · 2 copies · chains J, K, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17580.710.7762empty
21190.440.7714empty

Interfaces

38 interfaces between chains.

  • N–O · 849 Ų buried · 1 hydrogen bond · protein-protein
  • D–E · 809 Ų buried · 4 hydrogen bonds · protein-protein
  • O–P · 787 Ų buried · 6 hydrogen bonds · protein-protein
  • C–D · 783 Ų buried · 2 hydrogen bonds · protein-protein
  • K–L · 776 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 covalent (covalent ligand).

Compared structures

  • 6G68 · Crystal structure of a parallel six-helix coiled coil CC-Type2-IL-Sg · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.